EGRX - Class Action Lawsuit Filed on Behalf of Eagle Pharmaceuticals Inc. (EGRX) Investors – Nationally Ranked Investors' Rights Firm Holzer & Holzer LLC Encourages Investors With Significant Losses to Contact the Firm | Benzinga

ATLANTA, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC informs investors that a shareholder class action lawsuit has been filed against Eagle Pharmaceuticals, Inc. ("Eagle Pharmaceuticals" or the "Company") (NASDAQ:EGRX). The lawsuit alleges Eagle Pharmaceuticals made false or misleading statements and/or omitted material adverse information regarding the Company's business, operations, and prospects, including allegations that: (1) the Company was experiencing slower-than-anticipated pull-though from a wholesale customer predominantly due to expiry of inventory; (2) as a result, the Company had overstated its revenue; and (3) that the Company did not have ...

EGRX) Investors – Nationally Ranked Investors' Rights Firm Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm>Full story available on Benzinga.com